Posts Tagged ‘Zyprexa’

Clearing the Fog of Dementia Drugs

Wednesday, February 16th, 2011

Most of us agree that nursing home reform is a critical need in the United States. Many times, difficult behavior from people with dementia is managed by giving them more psychotropic drugs. As a result of these drugs, sometimes people go into a “fog” including lethargy, seem detached from the world,  stop speaking and other negative side effects.

This is a great article about Clearing the Fog at Nursing Homes – how behavioral interventions (and hands-on caring) changed residents from zombies to engaged adults at one nursing home in Two Harbors, Minn.  http://tinyurl.com/4oxw9kv

As the article states, behavioral interventions can be more costly to implement than prescribing, yet in the long run it can save money – not to mention the increased quality of life for the residents and families.

Even if your loved one with dementia is not in a nursing home, there are behavioral modifications you can use at home that might help them live a better life. Caring, and a loving touch can make a bigger difference than you might think.

Firm Pushed Drug It Knew Didn’t Work

Tuesday, June 16th, 2009

AP
Health insurers and states are suing Eli Lilly Co. over the way it marketed Zyprexa, an antipsychotic medication. Zyprexa was the firm’s best-selling drug in 2008.
(June 15) — Phamaceutical giant Eli Lilly & Co. urged doctors to prescribe its drug Zyprexa for elderly patients with dementia, even though the company had evidence the drug didn’t work in such cases, Bloomberg News reported.
The Bloomberg story is based on company documents that were unsealed in insurer lawsuits against the company over Zyprexa. Lilly began promoting the drug for use in elderly patients with Alzheimer’s and other forms of dementia in 1999, even though it had been approved only as a treatment for schizophrenia. The company also tried to get doctors to prescribe Zyprexa to elderly people struggling with moodiness and insomnia.

It’s unclear whether Lilly accepted the offer, Bloomberg said. It noted that a rival pharmacy company, Express Scripts Inc., also sent out letters touting Zyprexa. CVS and Express Scripts are not defendants in the lawsuit.
Zyprexa was Lilly’s best-selling drug in the U.S. in 2008, bringing in $14.6 billion. The documents were released as part of a $6.8 billion lawsuit over Lilly’s marketing of Zyprexa. Twelve states are also suing Lilly over the same matter.